| Application number | Title of the application | Filing Date | Status |
|---|
Array
(
[id] => 6377653
[patent_doc_number] => 20020119492
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-08-29
[patent_title] => 'Protein design automation for designing protein libraries with altered immunogenicity'
[patent_app_type] => new
[patent_app_number] => 09/903378
[patent_app_country] => US
[patent_app_date] => 2001-07-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 28405
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 60
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0119/20020119492.pdf
[firstpage_image] =>[orig_patent_app_number] => 09903378
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/903378 | Protein design automation for designing protein libraries with altered immunogenicity | Jul 9, 2001 | Abandoned |
Array
(
[id] => 6898920
[patent_doc_number] => 20010047085
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2001-11-29
[patent_title] => 'Process for viral inactivation of lyophilized blood proteins'
[patent_app_type] => new
[patent_app_number] => 09/894346
[patent_app_country] => US
[patent_app_date] => 2001-06-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 2138
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 75
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0047/20010047085.pdf
[firstpage_image] =>[orig_patent_app_number] => 09894346
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/894346 | Process for viral inactivation of lyophilized blood proteins | Jun 27, 2001 | Issued |
Array
(
[id] => 6617305
[patent_doc_number] => 20020064856
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-05-30
[patent_title] => 'Novel proteases'
[patent_app_type] => new
[patent_app_number] => 09/888615
[patent_app_country] => US
[patent_app_date] => 2001-06-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 69
[patent_figures_cnt] => 69
[patent_no_of_words] => 76811
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 272
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0064/20020064856.pdf
[firstpage_image] =>[orig_patent_app_number] => 09888615
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/888615 | Novel proteases | Jun 25, 2001 | Abandoned |
| 09/786362 | Method for screening and producing compound libraries | Jun 24, 2001 | Abandoned |
Array
(
[id] => 6934833
[patent_doc_number] => 20010056177
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2001-12-27
[patent_title] => 'Matrix granule'
[patent_app_type] => new
[patent_app_number] => 09/886244
[patent_app_country] => US
[patent_app_date] => 2001-06-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7673
[patent_no_of_claims] => 56
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0056/20010056177.pdf
[firstpage_image] =>[orig_patent_app_number] => 09886244
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/886244 | Matrix granule | Jun 19, 2001 | Abandoned |
| 09/787861 | Neuroimmunophilins for selective neuronal radioprotection | Jun 13, 2001 | Abandoned |
| 09/874708 | Nucleic acid molecules and other molecules associated with plants | Jun 4, 2001 | Abandoned |
Array
(
[id] => 1160482
[patent_doc_number] => 06759046
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2004-07-06
[patent_title] => 'Peptides'
[patent_app_type] => B1
[patent_app_number] => 09/674973
[patent_app_country] => US
[patent_app_date] => 2001-06-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 32708
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 11
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/759/06759046.pdf
[firstpage_image] =>[orig_patent_app_number] => 09674973
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/674973 | Peptides | Jun 3, 2001 | Issued |
Array
(
[id] => 1504963
[patent_doc_number] => 06465694
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-10-15
[patent_title] => 'Method for preparation of polyethylene glycol aldehyde derivatives'
[patent_app_type] => B1
[patent_app_number] => 09/830470
[patent_app_country] => US
[patent_app_date] => 2001-06-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4388
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 162
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/465/06465694.pdf
[firstpage_image] =>[orig_patent_app_number] => 09830470
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/830470 | Method for preparation of polyethylene glycol aldehyde derivatives | Jun 3, 2001 | Issued |
Array
(
[id] => 6801133
[patent_doc_number] => 20030096298
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-05-22
[patent_title] => 'Method of identifying peptides capable of binding to MHC molecules, peptides identified thereby and their uses'
[patent_app_type] => new
[patent_app_number] => 09/865548
[patent_app_country] => US
[patent_app_date] => 2001-05-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 33966
[patent_no_of_claims] => 50
[patent_no_of_ind_claims] => 14
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0096/20030096298.pdf
[firstpage_image] =>[orig_patent_app_number] => 09865548
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/865548 | Peptides capable of binding to MHC molecules, cells presenting such peptides, and pharmaceutical compositions comprising such peptides and/or cells | May 28, 2001 | Issued |
| 09/865419 | Nucleic acid molecules and other molecules associated with plants | May 28, 2001 | Abandoned |
Array
(
[id] => 6159471
[patent_doc_number] => 20020147301
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-10-10
[patent_title] => 'Parevins and tachytegrins'
[patent_app_type] => new
[patent_app_number] => 09/865943
[patent_app_country] => US
[patent_app_date] => 2001-05-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 12236
[patent_no_of_claims] => 47
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0147/20020147301.pdf
[firstpage_image] =>[orig_patent_app_number] => 09865943
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/865943 | Parevins and tachytegrins | May 23, 2001 | Abandoned |
| 09/744846 | Methods of using a somatostatin analogue | May 23, 2001 | Abandoned |
| 09/744350 | Encapsulation of water soluble peptides | May 21, 2001 | Abandoned |
Array
(
[id] => 6468222
[patent_doc_number] => 20020151028
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-10-17
[patent_title] => 'Structure-based drug design for Ulp1 protease substrates'
[patent_app_type] => new
[patent_app_number] => 09/856247
[patent_app_country] => US
[patent_app_date] => 2001-05-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 99119
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 5
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0151/20020151028.pdf
[firstpage_image] =>[orig_patent_app_number] => 09856247
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/856247 | Structure-based drug design for Ulp1 protease substrates | May 16, 2001 | Abandoned |
Array
(
[id] => 6016833
[patent_doc_number] => 20020103111
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-08-01
[patent_title] => 'Inhibitors of MAdCAM-1-mediated interactions and methods of use therefor'
[patent_app_type] => new
[patent_app_number] => 09/859214
[patent_app_country] => US
[patent_app_date] => 2001-05-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 19197
[patent_no_of_claims] => 70
[patent_no_of_ind_claims] => 13
[patent_words_short_claim] => 9
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0103/20020103111.pdf
[firstpage_image] =>[orig_patent_app_number] => 09859214
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/859214 | Inhibitors of MAdCAM-1-mediated interactions and methods of use therefor | May 15, 2001 | Abandoned |
Array
(
[id] => 6307851
[patent_doc_number] => 20020094957
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-07-18
[patent_title] => 'Peptide binding the KLVFF-sequence of amyloid-beta'
[patent_app_type] => new
[patent_app_number] => 09/850061
[patent_app_country] => US
[patent_app_date] => 2001-05-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 4515
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0094/20020094957.pdf
[firstpage_image] =>[orig_patent_app_number] => 09850061
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/850061 | Peptide binding the KLVFF-sequence of amyloid-beta | May 7, 2001 | Abandoned |
| 09/849529 | Nucleic acid molecules and other molecules associated with plants | May 6, 2001 | Abandoned |
| 09/831069 | Means and method for recursive partitioning analysis of large structure-activity data sets | May 4, 2001 | Abandoned |
Array
(
[id] => 579239
[patent_doc_number] => 07158888
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2007-01-02
[patent_title] => 'Determining structures by performing comparisons between molecular replacement results for multiple different biomolecules'
[patent_app_type] => utility
[patent_app_number] => 09/848866
[patent_app_country] => US
[patent_app_date] => 2001-05-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 13149
[patent_no_of_claims] => 57
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 112
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/158/07158888.pdf
[firstpage_image] =>[orig_patent_app_number] => 09848866
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/848866 | Determining structures by performing comparisons between molecular replacement results for multiple different biomolecules | May 3, 2001 | Issued |
